Elevated serum glutathione reflects endoscopic disease activity in inflammatory bowel disease

Serum GSH may serve as a systemic biomarker of endoscopic disease activity in IBD, particularly CD. While less accurate than fecal calprotectin alone, systemic oxidative stress markers strongly enhance its diagnostic performance, suggesting complementary value for disease monitoring.